Therapeutic efficacy of drilling drainage combined with intraoperative middle meningeal artery occlusion in the management of chronic subdural hematoma: a clinical study.
Chronic subdural hematoma (CSDH)
Cranial drilling and drainage
Middle meningeal artery (MMA)
Pathogenesis
Treatment
Journal
Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181
Informations de publication
Date de publication:
25 Jun 2024
25 Jun 2024
Historique:
received:
04
04
2024
accepted:
04
06
2024
revised:
27
05
2024
medline:
25
6
2024
pubmed:
25
6
2024
entrez:
24
6
2024
Statut:
epublish
Résumé
The bone holes in the skull during surgical drainage were accurately located at the site of the MMA. The MMA was severed, and the hematoma was removed intraoperatively; furthermore, surgical drainage removed the pathogenic factors of CSDH. This study aimed to describe and compare the results of the new treatment with those of traditional surgical drainage, and to investigate the relevance of this approach. From December 2021 to June 2023, 72 patients were randomly assigned to the observation group and the control group. The control group was treated with traditional surgical drainage, while the observation group was treated with DSA imaging to accurately locate the bone holes drilled in the skull on the MMA trunk before traditional surgical drainage. The MMA trunk was severed during the surgical drainage of the hematoma. The recurrence rate, time of indwelling drainage tube, complications, mRS, and other indicators of the two groups were compared, and the changes of cytokine components and imaging characteristics of the patients were collected and analyzed. Overall, 27 patients with 29-side hematoma in the observation group and 45 patients with 48-side hematoma in the control group were included in the study. The recurrence rate was 0/29 in the observation group and 4/48 in the control group, indicating that the recurrence rate in the observation group was lower than in the control group (P = .048). The mean indwelling time of the drainage tube in the observation group was 2.04 ± 0.61 days, and that in the control group was 2.48 ± 0.61 days. The indwelling time of the drainage tube in the observation group was shorter than in the control group (P = .003). No surgical complications were observed in the observation group or the control group. The differences in mRS scores before and after operation between the observation group and the control group were statistically significant (P < .001). The concentrations of cytokine IL6/IL8/IL10/VEGF in the hematoma fluid of the observation and control groups were significantly higher than those in venous blood (P < .001). After intraoperative irrigation and drainage, the concentrations of cytokines (IL6/IL8/IL10/VEGF) in the subdural hematoma fluid were significantly lower than they were preoperatively. In the observation group, the number of MMA on the hematoma side (11/29) before STA development was higher than that on the non-hematoma side (1/25), and the difference was statistically significant (P = .003). In patients with CSDH, accurately locating the MMA during surgical trepanation and drainage, severing the MMA during drainage, and properly draining the hematoma, can reduce the recurrence rate and retention time of drainage tubes, thereby significantly improving the postoperative mRS Score without increasing surgical complications.
Sections du résumé
BACKGROUND
BACKGROUND
The bone holes in the skull during surgical drainage were accurately located at the site of the MMA. The MMA was severed, and the hematoma was removed intraoperatively; furthermore, surgical drainage removed the pathogenic factors of CSDH. This study aimed to describe and compare the results of the new treatment with those of traditional surgical drainage, and to investigate the relevance of this approach.
METHODS
METHODS
From December 2021 to June 2023, 72 patients were randomly assigned to the observation group and the control group. The control group was treated with traditional surgical drainage, while the observation group was treated with DSA imaging to accurately locate the bone holes drilled in the skull on the MMA trunk before traditional surgical drainage. The MMA trunk was severed during the surgical drainage of the hematoma. The recurrence rate, time of indwelling drainage tube, complications, mRS, and other indicators of the two groups were compared, and the changes of cytokine components and imaging characteristics of the patients were collected and analyzed.
RESULTS
RESULTS
Overall, 27 patients with 29-side hematoma in the observation group and 45 patients with 48-side hematoma in the control group were included in the study. The recurrence rate was 0/29 in the observation group and 4/48 in the control group, indicating that the recurrence rate in the observation group was lower than in the control group (P = .048). The mean indwelling time of the drainage tube in the observation group was 2.04 ± 0.61 days, and that in the control group was 2.48 ± 0.61 days. The indwelling time of the drainage tube in the observation group was shorter than in the control group (P = .003). No surgical complications were observed in the observation group or the control group. The differences in mRS scores before and after operation between the observation group and the control group were statistically significant (P < .001). The concentrations of cytokine IL6/IL8/IL10/VEGF in the hematoma fluid of the observation and control groups were significantly higher than those in venous blood (P < .001). After intraoperative irrigation and drainage, the concentrations of cytokines (IL6/IL8/IL10/VEGF) in the subdural hematoma fluid were significantly lower than they were preoperatively. In the observation group, the number of MMA on the hematoma side (11/29) before STA development was higher than that on the non-hematoma side (1/25), and the difference was statistically significant (P = .003).
CONCLUSION
CONCLUSIONS
In patients with CSDH, accurately locating the MMA during surgical trepanation and drainage, severing the MMA during drainage, and properly draining the hematoma, can reduce the recurrence rate and retention time of drainage tubes, thereby significantly improving the postoperative mRS Score without increasing surgical complications.
Identifiants
pubmed: 38914867
doi: 10.1007/s10143-024-02501-1
pii: 10.1007/s10143-024-02501-1
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
293Informations de copyright
© 2024. The Author(s).
Références
Yordanov S, Khan S, Stubbs D et al (2023) Assessing the accuracy of the International classification of Disease (ICD) framework in the identification of patients with chronic subdural haematoma from hospital records. Surgeon 21(5):e271–e278
doi: 10.1016/j.surge.2023.02.001
pubmed: 36967307
Chari A, Hocking KC, Broughton E et al (2016) Core outcomes and common data elements in chronic subdural hematoma: a systematic review of the literature focusing on reported outcomes[J]. J Neurotrauma 33(13):1212–1219
doi: 10.1089/neu.2015.3983
pubmed: 26295586
pmcid: 4931358
Sricatsan A, Srinica VM, Thomas A et al (2019) Perspective on safety and effectiveness of middle meningeal artery embolization for chronic subdural hematoma[J]. World Neurosurg 127:97–98
doi: 10.1016/j.wneu.2019.03.210
Uno M, Toi H, Hirai S Chronic subdural hematoma in elderly patients: is this disease benign?[J]. Neurol Med Chir (Tokyo) 2017, 57(8): 402–409
Balser D, Farooq S, Mehmood T et al (2015) Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations [J]. J Neurosurg 123:1209–1215
doi: 10.3171/2014.9.JNS141550
pubmed: 25794342
pmcid: 4575892
Holl DC, Volovici V, Dirven CMF et al (2018) Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future[J]. World Neurosurg 116:402–411e2
doi: 10.1016/j.wneu.2018.05.037
pubmed: 29772364
Georgios S (2024) Sioutas,a Ahmad Sweid,a Ching-Jen Chen,et al.Surgical evacuation for chronic subdural hematoma: predictors of reoperation and functional outcomes. World Neurosurg X 21:100246
doi: 10.1016/j.wnsx.2023.100246
Dian J, Linton J, Shankar JJ (2021) Risk of recurrence ofsubdural hematoma after EMMA vs surgical drainage-systematic review and Meta-analysis. Interv Neuroradiol 27(4):577–583
doi: 10.1177/1591019921990962
pubmed: 33525919
pmcid: 8392769
Mori K, Maeda M (2001) Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate[J]. Neurol Med Chir (Tokyo) 41(8):371–373 8 1
doi: 10.2176/nmc.41.371
pubmed: 11561347
Cheng SY, Chang CK, Chen SJ et al (2014) Chronic subdural hematoma in Elderly Taiwan patients: a retrospective analysis of 342 Surgical Cases[J]. Int J Gerontol 8(1):37–41
doi: 10.1016/j.ijge.2014.01.001
Ramachandran R, Hegde T (2007) Chronic subdural hematomas causes of morbidity and mortality[J]. Surg Neurol 67(4):367–372
doi: 10.1016/j.surneu.2006.07.022
pubmed: 17350403
Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut A et al (2005) Chronic subdural haematoma: surgical treatment and outcome in 1000 cases[J]. Clin Neurol Neurosurg 107(3):223–229
doi: 10.1016/j.clineuro.2004.09.015
pubmed: 15823679
Kanyi JK, Ogada TV, Oloo MJ et al (2018) Burr-Hole Craniostomy for Chronic Subdural hematomas by General surgeons in Rural Kenya[J]. World J Surg 42(1):40–45
doi: 10.1007/s00268-017-4143-z
pubmed: 28741193
Hiroaki M, Atsushi M, Shiro M et al (2023) The Effect of Japanese Herbal Medicines (Kampo) Goreisan and Saireito on the Prevention of Recurrent Chronic Subdural Hematoma: a prospective Randomized Study, vol 8. Neurosurgery, pp 1–10. 28
Santarius T, Kirkpatrick PJ, Kolias AG et al (2010) Working toward rational and evidence-based treatment of chronic subdural hematoma [J]. Clin Neurosurg 57:112–122
pubmed: 21280503
Regan JM, Worley E, Shelburne C et al (2015) Burr hole washout versus craniotomy for chronic subdural hematoma: patient outcome and cost analysis[J]. PLoS ONE 10(1):e0115085
doi: 10.1371/journal.pone.0115085
pubmed: 25611468
pmcid: 4303411
Rickard F, Gale J, Williams A et al (2023) New horizons in subdural haematoma. Age Ageing 52(12):240
doi: 10.1093/ageing/afad240
Jin E, Stephen A, Min H et al (2023) Balancing bleeding risk and thromboembolic complications in Elderly Chronic Subdural Hematoma patients Undergoing Burr Hole Trephination : a Multicenter Retrospective Cohort Study and Literature. Rev J Korean Neurosurg Soc Nov; 66(6):726–734
doi: 10.3340/jkns.2023.0115
Gernsback J, Kolcun JP, Jagid J (2016) To drain or two drains: recurrences in chronic subdural hematomas [J]. World Neurosurg 95:447–450
doi: 10.1016/j.wneu.2016.08.069
pubmed: 27567570
Waqas M, Vakhari K, Weimer PV et al (2019) Safety and effectiveness of embolization for chronic subdural hematoma: systematic review and case series[J]. World Neurosurg 126:228–236
doi: 10.1016/j.wneu.2019.02.208
pubmed: 30878752
Toi H, Fujii Y, Iwama T et al (2019) Determining if cerebro-spinal fluid prevents recurrence of chronic subdural hemato-ma: a multi-center prospective randomized clinical trial [J]. J Neurotrauma 36(4):559–564
doi: 10.1089/neu.2018.5821
pubmed: 29901422
Huang J, Tian Y, Song Y (2019) Et a1.Effect of different factors on the short-term outcome of Chinese patients with primary chronic subdural hematoma at different age groups: a two-center retrospective study[J]. Front Aging Neurosci 11(11):325–336
doi: 10.3389/fnagi.2019.00325
pubmed: 31849637
pmcid: 6895020
Onyinzo C, Berlis A, Abel M et al (2022) Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone[J ]. J Neurointerv Surg 14(3):297–300
doi: 10.1136/neurintsurg-2021-017450
pubmed: 34187870
Masaaki U (2023) Chronic subdural hematoma-evolution of etiology and Surgical Treatment. Neurol Med Chir (Tokyo) 63(1):1–8
doi: 10.2176/jns-nmc.2022-0207
Moshayedi P, Liebeskind DS (2020) Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in Trial Design [J]. Front Neurol 11:923
doi: 10.3389/fneur.2020.00923
pubmed: 32973670
pmcid: 7481478
Link TW, Rapoport BI, Paine SM et al (2018) Middle meningeal artery embolization for chronic subdural hematoma: endovascular [J]. Interventional Neuroradiology: J Peritherapeutic Neuroradiol 24(4):455–462
doi: 10.1177/1591019918769336
Liu HB, Yan RD, Xie F et al (2022) Hematoma cavity separation and neomembrane thickness are potential triggers of recurrence of chronic subdural hematoma. BMC Surg 22(1):236
doi: 10.1186/s12893-022-01687-9
pubmed: 35725399
pmcid: 9210812
Chang CL, Sim JL, Delgardo MW et al (2020) Predicting Chronic Subdural Hematoma Resolution and Time to Resolution following Surgical Evacuation. Front Neurol 11:677
doi: 10.3389/fneur.2020.00677
pubmed: 32760342
pmcid: 7371920
Mandai S, Sakurai M, Matsumoto Y (2000) Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report[J] J Neurosurg 93(4):686–688
doi: 10.3171/jns.2000.93.4.0686
pubmed: 11014549
Mowla A, Abdollahifard S, Farrokhi A et al (2023) Middle meningeal artery embolization with Liquid Embolic agents for chronic subdural hematoma: a systematic review and Meta-analysis.J Vasc Interv Radiol. 34(9):1493–1500e7
Ban SP, Hwang G, Byoun HS et al (2018) Middle Meningeal Artery Embolization for Chronic Subdural Hematoma.[Z]. : 286, 992–999
Fareed J, Muhammad O, Abdurrahman II et al (2020) Efficacy and safety of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas: a systematic review and meta-analysis. Acta Neurochir (Wien) 162(3):499–507
doi: 10.1007/s00701-019-04161-3
Link TW, Boddu S, Marcus J et al (2018) Middle meningeal artery embolization as treatment for chronic subdural hematoma: [Z]. 14, pp 556–562
Atakan O, Yigit CS, Cem B et al (2023) Middle meningeal artery embolization without surgical evacuation for chronic subdural hematoma: a single-center experience of 209 cases. Front Neurol 14:1222131
doi: 10.3389/fneur.2023.1222131
James F, Wuyang Y, Judy H (2020) Updates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome. World Neurosurg. Sep:141:339–345
Dalibor S, Francisco LC, Mária V et al (2023) Middle meningeal artery embolization versus surgery in patients with chronic subdural Hematoma-No more fence sitting? Neurol Int 15(4):1480–1488
doi: 10.3390/neurolint15040096
Natasha I, Candice N, Quan D (2021) Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg 13(10):951–957
doi: 10.1136/neurintsurg-2021-017352
Joshua D, Janice L, Jai JS (2021) Risk of recurrence of subdural hematoma after EMMA vs surgical drainage - systematic review and meta-analysis. Interv Neuroradiol 27(4):577–583
doi: 10.1177/1591019921990962
Yoshihiro O, Taichi I (2023 Oct) Middle meningeal artery embolization for chronic subdural hematoma: a systematic review. Front Neurol 10:141259647
Liu ZS, Wang YW, Tang TY et al Time and influencing factors to Chronic Subdural Hematoma Resolution after Middle Meningeal artery embolization. World Neurosurg 2023 Nov :179:e6–e14
Lucio DM, Bipin C, Edoardo A et al Non-surgical management of chronic subdural hematoma: insights and future perspectives from an international survey including neurosurgeons from 90 countries worldwide. Int J Neurosci 2023 Nov 20:1–10
Saeed A, Amirmohammad F, Omid Y et al (2022 Sep) Particle embolic agents for embolization of middle meningeal artery in the treatment of chronic subdural hematoma: a systematic review and meta-analysis. Interv Neuroradiol 13:15910199221125977
Ken T, Takatoshi S, Hideo I et al (2016) Enlargement of the middle meningeal artery on MR Angiography in chronic subdural hematoma. J Neurosurg 124(6):1679–1683
doi: 10.3171/2015.5.JNS1567
Xu HC, Huang X, Xu J et al (2023) Enlargement of the Middle Meningeal Artery may be an initiating factor of chronic subdural hematoma: three rase reports and a literature review. Curr Med Imaging. Mar 24
Bartley A, Bartek J, Jakola AS et al (2023) Effect of Irrigation Fluid temperature on recurrence in the evacuation of chronic subdural hematoma. JAMA Neurol 80(1):58–63
doi: 10.1001/jamaneurol.2022.4133
pubmed: 36409480
Kim E (2017) Embolization Therapy for Refractory Hemorrhage in patients with chronic subdural [J]. World Neurosurg 101:520–527
doi: 10.1016/j.wneu.2017.02.070
pubmed: 28249828